Genomtec Statistics

Total Valuation

Genomtec has a market cap or net worth of PLN 67.94 million. The enterprise value is 62.67 million.

Market Cap	67.94M
Enterprise Value	62.67M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Genomtec has 15.06 million shares outstanding. The number of shares has increased by 12.82% in one year.

Current Share Class	15.06M
Shares Outstanding	15.06M
Shares Change (YoY)	+12.82%
Shares Change (QoQ)	+3.99%
Owned by Insiders (%)	9.00%
Owned by Institutions (%)	3.32%
Float	12.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4,529.43
PB Ratio	6.57
P/TBV Ratio	6.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.69
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.21.

Current Ratio	2.82
Quick Ratio	2.48
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-73.38

Financial Efficiency

Return on equity (ROE) is -111.03% and return on invested capital (ROIC) is -54.29%.

Return on Equity (ROE)	-111.03%
Return on Assets (ROA)	-40.36%
Return on Invested Capital (ROIC)	-54.29%
Return on Capital Employed (ROCE)	-84.46%
Revenue Per Employee	577
Profits Per Employee	-423,423
Employee Count	26
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-73,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.01% in the last 52 weeks. The beta is 0.16, so Genomtec's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	-35.01%
50-Day Moving Average	5.59
200-Day Moving Average	6.72
Relative Strength Index (RSI)	35.30
Average Volume (20 Days)	28,380

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genomtec had revenue of PLN 15,000 and -11.01 million in losses. Loss per share was -0.73.

Revenue	15,000
Gross Profit	-8.12M
Operating Income	-10.86M
Pretax Income	-11.08M
Net Income	-11.01M
EBITDA	-8.16M
EBIT	-10.86M
Loss Per Share	-0.73

Full Income Statement

Balance Sheet

The company has 7.40 million in cash and 2.13 million in debt, giving a net cash position of 5.27 million or 0.35 per share.

Cash & Cash Equivalents	7.40M
Total Debt	2.13M
Net Cash	5.27M
Net Cash Per Share	0.35
Equity (Book Value)	10.35M
Book Value Per Share	0.69
Working Capital	6.05M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-72,400.00%
Pretax Margin	-73,880.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genomtec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.82%
Shareholder Yield	-12.82%
Earnings Yield	-16.20%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Genomtec has an Altman Z-Score of 7.12 and a Piotroski F-Score of 2.

Altman Z-Score	7.12
Piotroski F-Score	2